民营医疗风口已来临 规模化、集约化、集聚化将成为医疗服务发展方向

2018-04-20 丁琪 猎云网

根据数据统计,2011年医疗健康的产业规模在1.6万亿,2017年已经增长到5.1万亿。根据健康中国2030的规划纲要,预计在2020年我国的健康产业总规模也将会超过8万亿元,医疗健康将会孕育出巨大的发展前景。在医疗健康产业发展蓬勃的过程中,自然催生和加速了医疗健康领域投资并购呈现出平稳、快速的上升趋势,也引发了各界人士对于医疗健康产业、资本、政策的关注。4月18-4月20日,“2018CH

根据数据统计,2011年医疗健康的产业规模在1.6万亿,2017年已经增长到5.1万亿。根据健康中国2030的规划纲要,预计在2020年我国的健康产业总规模也将会超过8万亿元,医疗健康将会孕育出巨大的发展前景。

在医疗健康产业发展蓬勃的过程中,自然催生和加速了医疗健康领域投资并购呈现出平稳、快速的上升趋势,也引发了各界人士对于医疗健康产业、资本、政策的关注。4月18-4月20日,“2018CHC·中信证券医疗健康大会暨第七届中国医疗健康产业投资与并购CEO峰会”在上海顺利召开。

在医疗服务分会场上,围绕民营医疗风口已来临为主题,杏仁医生创始人马丁、安翰医疗董事长吉朋松、爱尔眼科经营院长陈瑾、张强医生集团创始人张强、中卫基金合伙人李文罡等嘉宾共同探讨了民营医疗的核心竞争力、医生集团及共享医疗、人工智能和互联网医疗、新诊所等热门话题。

据公开资料显示,目前我国民营医院的数量已超过公立医院的数量,床位数超过25%,同时,这几年民营医院总体诊疗人数和出院人数也保持着两位数的增长,16%和20%。国家卫生健康委体改司副司长庄宁表示,在整个增长相对平缓的情况下,民营医院将是未来健康服务业、健康产业发展的供给侧改革的异军突起的力量。

在此背景下,对于民营医院来说,如何打造各自的竞争力就成了首先需要思考的问题。那究竟什么是核心竞争力?如何打造民营医院的核心竞争力?中卫基金合伙人李文罡认为,对于不同的医疗服务机构来说,核心竞争力存在差异;因此,首先应该建立好自己的战略定位,明确自己的竞争对手后再去寻找差异化竞争路线。

以爱尔眼科为例,在战略定位上,爱尔眼科走的就是一条学科差异化的道路。爱尔眼科经营院长陈瑾表示,爱尔眼科从最开始就清楚自己的定位,专注于眼科,其次,采用分级连锁的商业模式;在人才培养上,通过成立眼科学院来实现自我产血;两条腿走路,通过基础的医疗保生存,重点发展中高端的医疗来推动发展。

除了人才培养之外,上海德济医院董事长兼执行院长郭辉认为,建立好非公立医院的核心竞争力,学科建设也很重要。其中,学科建设分两个方面,第一是人才,第二是技术;技术和人才能够奠定学科的高度,也能够实现与公立医院之间的错位竞争。

无论是学科建设还是人才培养,对于医疗服务来说,其本质都是为了保证临床的质量。但要想生存和发展,私立医院就需要从管理、效率、品牌等多方面协同发力,尤其是一开始发展初期就要提升自己的品牌和影响力,包括综合能力。

在品牌建设方面,三博脑科集团常务副总蔡泓斌用“十年磨一剑”来概括其核心要素。在火热的医疗大环境中,一定要踏踏实实地把医疗服务做好。“临床和治疗达到治病就医效果的同时,还需要给患者带来亲近感和信任感。”德达医疗首席商务官张玲说道。

这种亲近感和信任感在医生与患者的互动中显得尤为重要,在目前火热的互联网医疗中也多次被重点提到,平安好医生即将赴港上市,微医也传出今年年底会IPO的消息,有人认为互联网医疗已经进入下半场。

那对于今天进入互联网医疗的企业来说,还有新的机会吗?安翰医疗副总裁郇丹丹认为,颠覆性的创新都是从小公司开始的,对于创业公司来说,可以关注大的公司还在观望的点做颠覆性的创新,核心还是打造自己的技术上原创性核心竞争力,通过自己的原创性技术来形成竞争的壁垒。

乐普医疗集团副总裁陈娟则从人工智能方向做了解读,她表示,目前中国最稀缺的是医生资源,因此,创业公司需要转型,从而让现在稀缺的医生资源发挥更大的效能,通过AI、大数据等等的技术普及实现两个方向;第一,逐渐普及到基层,第二,分析出高质量的数据。

除了从技术角度推进之外,为了给广大的人群群众更好的医疗服务,为了充分发挥医生的效能,政府也出台多项政策大力地支持医生的多点执业。

在上星期国家卫计委的座谈会中,卫计委对医生集团作出明确的定义,两个医生以上,联合执业,收入来源中70%应该是来源于医疗服务的。从2014年,张强建立第一个国内医生集团——张强医生集团开始,经过3年多的发展,中国目前已经有超过四百家的医生集团。

但从行业发展阶段来看,张强医生集团创始人张强认为,目前国内大部分医生集团还处在1.0阶段,部分医生集团已经进入2.0阶段。而阻碍医生集团发展的主要原因在于两方面:优秀医疗机构不多,商业医疗保险太落后,冬雷脑科医生集团创始人宋冬雷补充道。

从投资人角度来说,同伟创业合伙人汪洋表示;医生集团相对来说是轻资产的,但是必须要有自己的独到技术能力,去解决技术上的问题,这样才能竖立起自己的品牌。另外,医生集团需要建立好自己的商业模式。

在资本和医疗集团企业的对接方面,不同于现金流良好的美国医生集团业态,由于中国环境的特殊性,资本市场跟医生集团的结合,在张强看来是大有市场的。目前中国医疗品牌还处于空白的阶段,医生集团的品牌可扩展性和轻资产属性等方面,都给资本市场提供了机会。

因此,与现在火热的移动医疗相比,张强认为医生集团估值会超过现在的移动医疗公司,主要基于以下三个方面,第一、从互联网角度来说,未来的传统医院会面临巨大的挑战,医院的功能将会全部拆分,体现在独立的日间手术中心在最近五年之内一定会成为热点;支付手段一跟上,剩下的就是ICU、急诊和重大疑难手术,将不会再有门诊;这是互联网提供的巨大机遇。

第二、中国大量的资本会在某个节点上助推医生集团,但从医生团队到医生集团,对于医生的考验是非常大,因此医生集团需要做内功,了解运营和管理。第三、科技的发展使医生过去的技术性劳动可以成倍地放大效力,提高效能。总结来说,互联网、资本、科技的加持能够让医生集团发展的更好。

在互联网的时代,共享经济从消费领域慢慢发展到医疗服务领域。“共享一定是未来的方向。医生集团无论从哪个角度来说,它是医疗行为的核心,医生和病人,这个核心下所有的资源怎么对接服务,这就是我们共享未来,因为有医生集团,天然有共享的特质,国家又出了政策,所以这是我认为未来比较容易推动的。”张强回答道。

宋冬雷从另一角度给出了解读,他认为共享医疗就是一种方式,医生集团既是共享医疗的实践者,也是提供者,但提供的是医院。

总的来说,不管是对于医生集团、互联网医疗还是民营医疗机构,“未来医疗服务可能更多的倾向于综合整合,各要素处于动态变化当中,规模化、集约化、集聚化将成为发展方向,同时在经营方式的专业化方面,将对管理者提出更高的要求。”庄宁说道。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-26 1ddf0692m34(暂无匿称)

    学习了.谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 神功盖世

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 12225669m29暂无昵称

    是嘛

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1752531, encodeId=c4a41e52531a6, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Mon Nov 12 03:47:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056403, encodeId=1f6820564036b, content=<a href='/topic/show?id=541163e44cb' target=_blank style='color:#2F92EE;'>#民营医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63744, encryptionId=541163e44cb, topicName=民营医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Sat Feb 09 07:47:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915667, encodeId=ab96191566ece, content=<a href='/topic/show?id=8d833e840ae' target=_blank style='color:#2F92EE;'>#发展方向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37840, encryptionId=8d833e840ae, topicName=发展方向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Feb 04 00:47:00 CST 2019, time=2019-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309530, encodeId=f56e3095302a, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Apr 26 18:01:51 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303551, encodeId=744e1303551a2, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Sun Apr 22 13:47:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307860, encodeId=a97a30e860b0, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Apr 21 08:42:32 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307777, encodeId=6ce830e777c2, content=是嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9572310056, createdName=12225669m29暂无昵称, createdTime=Sat Apr 21 06:44:19 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307728, encodeId=e9b430e728a9, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:12:03 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 飛歌

    学习了很有用

    0

相关资讯

社会办医再获国务院力挺 告别“打肿脸充胖子”

1月17日,2018年的第二次国务院常务会议,在上海浦东新区试点取消社会办医乙类大型医用设备配置许可证核发等审批。这意味着,相比公立医院,社会办医在购买CT、MRI等5种乙类医用大设备上,头一回获得了优先权,也有了更大的自主权。也意味着,国家对社会办医的支持已经深入细部,着力从细节解决难题。

从野蛮扩张到有序发展,民营医疗下一步需要解决什么?

民营医疗的发展可以分为三个阶段。1.0时代是1993年到2003年,以老板为中心,以赚钱为目的;2.0时代是2003年到2013年,以医生为中心,以发展为目的;3.0时代从2013年开始,以患者为中心,以口碑为目的。

民营医疗机构频频打擦边球 监管如何跟上

由于医疗卫生行业的特点和复杂性,监管必须全程覆盖,从投资者资质、利润流向、区域卫生规划、质量安全等方面进行全方位监管,建立退出机制。